It has been reported that CXCR4-overexpressing mesenchymal stem cells (MSC CX4 ) can repair heart tissue post myocardial infarction. This study aims to investigate the MSCCX4-derived paracrine cardio-protective signaling in the presence of myocardial infarction. Mesenchymal stem cells (MSCs) were divided into 3 groups: MSC only, MSC CX4 , and CXCR4 gene-specific siRNAtransduced MSC. Mesenchymal stem cells were exposed to hypoxia, and then MSCs-conditioned culture medium was incubated with neonatal and adult cardiomyocytes, respectively. Cell proliferation-regulating genes were assessed by real-time polymerase chain reaction (RT-PCR).
(TGF-β). 7 Although the adult heart has limited capacity for myocyte proliferation, these new discoveries raise the possibility that increasing the number of the existing cardiomyocytes by activating their proliferative potential can replace damaged myocardium following infarction.
Therefore, genetic manipulations may be important in enhancing cardiomyocyte proliferation and differentiation from MSC or native cardiomyocytes for cardiac repair.
CXCR4 is a major regulator of stem/progenitor cell activities. 8 The importance of stromal cell-derived factor (SDF)-1α/CXCR4 signaling is documented in CXCR4 knockout mice, which die in utero, thereby indicating a fundamental developmental role for this receptor-ligand axis. 9 Pretreatment of cells with small molecules, such as statins, p38 MAP kinase inhibitors, or endothelial nitric oxide synthase enhancers, has been used to augment cell proliferation and functional recovery after induction of ischemia. 10 In this study, we hypothesize that CXCR4 overexpression enhances cell proliferation and releasing paracrine factors from mesenchymal stem cell (MSC). Our data show that CXCR4-overexpressing mesenchymal stem cells (MSC CX4 ) secrete multiple cytokines such as vascular endothelial growth factor (VEGF), cyclin A2, and TGF-β2 in response to hypoxia, augmenting endogenous regenerative processes and cell cycle re-entry. The observation that conditioned medium from MSC CX4 induces differentiation of MSC into endothelial cells and alleviates heart remodeling provides mechanistic support for the superior regenerative capacity of MSC CX4 that may provide an improved alternative to future therapies following myocardial infarction (MI). interfering RNA (siRNA) in MSC. GFP-tagged adenovirus containing CXCR4-encoding gene (Ad CXCR4) was prepared as previously described, and the adenovirus containing non-coding gene (Ad Null) was treated as control. 11 The vectors were propagated in 293 cells and purified on a CsCl 2 gradient. For gene transduction, MSC were exposed to the respective virus (1 × 10 9 particles/ml) for 8 hours and kept in culture for an additional 24 hours in Dulbecco's modified Eagle's medium (DMEM) medium without the viral vector. The transduction procedure was repeated 3 times to achieve optimal transduction efficiency. We chose adenovirus-based siRNA constructs to express siRNA to knock down CXCR4. The method for transfection of siRNA in MSC has been described previously in detail. 11 3 | IN VITRO STUDIES
| Preparation of conditioned medium
We used MSC CX4 with MSC Null as a control to study the effects of CXCR4 overexpression. Parent MSC (MSC Par ) served as an additional control to rule out confounding effects of green fluorescent protein (GFP) transduction and expression. To block the effects of endogenous CXCR4, we used an additional group with adenovirus containing siRNA targeting the CXCR4 gene (MSC siR ). Conditioned medium was collected from each group of MSC grown under normal or hypoxic conditions for 8 hours. As a negative control, fresh culture medium (not exposed to cells) was used. Fibroblast growth factor (FGF) (100 ng/ml; R&D systems) was used as a positive control. FGF plus MSC CX4 conditioned medium was used to study their additive effect. Conditioned medium was concentrated with Millipore Solvent Resistant Cell (Millipore) and then added to the neonatal cardiomyocytes in different dilutions (1/1000, 1/100, and 1/10) for dose-dependent effects.
| CARDIOMYOCYTE ISOLATION AND CULTURE
For positive control, primary cultures of the neonatal rat cardiomyocytes were prepared as we described previously. 12 Briefly, ventricular cardiomyocytes from 2-day-old rat neonatal hearts and adult hearts (200-250 g) were isolated as described with minor modifications. 12 After digestion of rat neonatal hearts (0.14 mg/mL collage- BSA, penicillin [100 U/mL], and streptomycin [100 μg/mL]). Cells were stimulated in culture medium without BSA containing 2 mM L-glutamine. Neonatal and adult cardiomyocytes were initially cultured for 48 hours in the presence of 20 μM cytosine β-D-arabinofuranoside (araC; Sigma) and 5% horse serum before treatment to prevent proliferation of noncardiomyocytes. Adult cardiomyocytes were incubated for another 3 days with araC during treatment. Bromodeoxyuridine (BrdU) (30 μM) was added for the last 3 days. Cells were then divided into the various treatment groups mentioned above. To determine the effects of conditioned medium on proliferation of neonatal and adult cardiomyocytes in vitro, we added concentrated control medium or conditioned medium from hypoxic and normoxic MSC Null , MSC CX4 , or MSC Par to the dishes (n = 6 per group) at the dilutions described above. To determine their additive effect on cell proliferation, we also treated neonatal and adult rat cardiomyocytes with FGF (100 ng/ml; R&D systems), which is known to induce cardiomyocyte division, 13 combined with MSC CX4 conditioned medium. Primary neonatal and adult rat cardiomyocytes were examined and quantified with a hemocytometer after 4 and 7 days of treatment with conditioned medium.
Corresponding samples were stained for the cardiomyocyte marker troponin I to determine the percentage of differentiated cardiomyocytes. To count cardiomyocyte number, we incubated cardiomyocytes with 0.2 μg/ml of Hoechst 33342 (Invitrogen) for 10 minutes and nuclei were then counted in 4 random ×20 microscopic fields. 3 The method for preparation of MSC has been previously described in detail. 10 Passage 2 to 4 MSC were used in the study. So as to mimic the ischemic injury in vitro, the culture medium was then immediately Normal culture (serum-free regular medium under 21% O 2 and 5% CO 2 ) served as a control. Cells were reoxygenated by replacing ischemic buffer with culture medium at 5% CO 2 and 37°C for another 18 hours as previously described. 14 gel electrophoresis stained with ethidium bromide. 15 We repeated individual experiments at least 3 times, and calculated the ratio of the density of target cDNA to that of GAPDH in each experiment. 
| Preparation of MSC and RT-PCR analysis

RNA of MSC was extracted after various treatments under
| Immunofluorescence microscopy
| In vitro tube formation assay
A tube formation assay was performed with a tube formation assay kit (Chemicon) according to the manufacturer's instructions. Briefly, the solution of ECMatrix was thawed on ice overnight, mixed with 10 diluents of ECMatrix and placed in a 96-well tissue culture plate at 37°C for 1 hour to allow the matrix solution to solidify. The MSC Null , or MSC CX , or MSC siR were exposed to hypoxic conditions for 48 hours. They were then seeded (5 × 10 3 cells/well) on top of the solidified matrigel and incubated at 37°C for 4 hours. After cellular network structures were fully developed, the total capillary tube number was measured under an inverted light microscope (Olympus America, Melville, New York) at 200 magnification. Five independent fields were assessed for each well, and the average number of tubes was determined. Networks of tube-like structures were measured using Image Pro Plus software 6.0 (MediaCybernetic, Silver Spring, Massachusetts).
| IN VIVO STUDIES
| Surgical procedures for left anterior descending artery ligation and experimental groups
An MI model was developed in female Sprague-Dawley rats, 200 to 250 g (n = 18/group), as we previously described. 15 Rats were anesthetized with isoflurane and a midline cervical skin incision was performed for intubation. The animals were mechanically ventilated with room air supplemented with oxygen (1.5 L/min) using a rodent ventilator (Model 683, Harvard Apparatus, South Natick, Massachusetts). Body temperature was carefully monitored with a probe (Cole-Parmer Instrument, Vernon Hills, Illinois) and maintained at 37°C throughout the surgical procedure. The heart was exposed by left side limited thoracotomy and left anterior descending artery (LAD) was ligated with a 6-0 polyester suture 1 mm from the tip of the normally positioned left auricle. We identified transferred MSC by simultaneous presence of GFP from genetically engineered rat MSC previously treated with an ex vivo adenoviral transduction method for Null/GFP (MSC Null ), or overexpressing CXCR4/GFP (MSC CX4 ), or siRNA targeting CXCR4 (MSC siR ) (11) . Thirty minutes after LAD ligation, the animals were divided into 3 groups and 2 × 10 6 MSC Null served as control, MSC CX4 , or MSC siR were injected into at risk areas. A sham group (chest opened without LAD ligation) served as an additional control. Heart tissue was harvested for immunohistochemical studies.
| MSC homing following MSC infusion
One month post-MI, tissue was prepared as described above for immunostaining. 11 The number of GFP + cells was quantified in the infarct zone by independent blinded researchers across a minimum of 4 sections from the midleft ventricle (LV) per animal.
| Immunohistochemistry for detection of angiogenesis
One month post-MI, the immunohistochemical studies were performed as described previously. 11 Endothelial cells were identified using CD31 antibody (PECAM-1, Santa Cruz Biotechnology). California,), and the percentage of the fibrotic area was calculated as previously described 16 (Fibrosis area/total LV area) × 100. Figure 1H ), similar to the effect of FGF (28.4 ± 2.6%). The additive effect of MSC CX4 -conditioned medium and FGF on cardiomyocyte DNA synthesis was the highest (51.3 ± 4.1%, Figure 1H ). The proliferation of neonatal cardiomyocytes in the MSC CX4 group was significantly higher as compared with control groups (Figure 1I ). Figure 2I ), suggesting the important role of MSC CX4 -conditioned medium in cardiomyocyte proliferation.
| Assessment of heart function
| Overexpression of CXCR4 enhanced the angiogenesis in MSCs
The tube formation assay was performed on matrigel-precoated wells.
The MSC Null exhibited small round shapes, isolated cells, and minimal migration under in hypoxia ( Figure 3A ). However, MSC CX led to the development of capillary tubes, the sprouting of new capillaries, and finally, the formation of cellular networks ( Figure 3B ). The number of these increased tube-like structures was abolished in MSC siR group ( Figure 3C ). The number of tube-like structures was significantly increased in MSC CX4 as compared to MSC Null or MSC siR under hypoxia (P < .05, Figure 3D ). Figure 4C) ; and transforming growth factor-ß2 (TGFß2), a mediator of growth and differentiation ( Figure 4D ). Our RT-PCR data also showed that VEGF, cyclin A2, and TGFß2 were significantly (Figure 4 ).
| Genetically modified MSC CX4 expresses cytoprotective and proliferative genes
| Immunohistochemical evidence for cell mobilization
Transplanted cells were identified by EGFP (green) ( Figure 5 ). MSCs migrated into the MI scar and per infarcted area ( Figure 4A 1-6 ). As A4-A6 and Figure 5A7 ). However, MSC homing was blocked by siRNA against CXCR4 in MSC siR group (picture panel not shown, which is similar to MSC Null group) and the number of EGFP positive cells per randomly chosen field did not differ between MSC Null (Figure 5A7 ). (Figure 5B1 ) or MSC siR groups ( Figure 5B3 ). The number of endothelial cells per randomly chosen field did not differ between MSC Null (12.6 ± 3.4) and MSC siR (14.2 ± 4.7) . However, the number of CD31 positive cells was the highest as compare with any other groups (P < .01; Figure 5B4 ). Figure 6A ). We also analyzed ventricular remodeling by measuring the thickness of the LV free wall and the interventricular septum at 4 weeks after MI ( Figure 6B ). The LV free wall was significantly thicker while that of the LV septum was no different in the MSC CX4 group as compared to the MSC CX4 or MSC siR groups ( Figure 6B) . These results indicate that transplantation of MSC CX4 reduced infarct size and improved ventricular remodeling.
We analyzed cardiac function at 4 weeks after MI by LV catheterization during preload reduction ( Figure 6C ) (Figure 6C4 ).
However, there was no significant difference in these parameters 18 Kuhn et al showed that adult cardiomyocytes can be stimulated to reenter the cell cycle with periostin, a ligand for α V ß 3 and α V ß 5 integrins. 3 Singla DK et al demonstrated that treatment of mouse Embryonic stem (ES) cells with TGF-β2 but not TGF-β1 or TGF-β3, induced significant increased embryoid body proliferation as well as an increase in the number of beating cardiac myocytes. 19 Additionally, targeted expression of cyclin A2 led to augmented endogenous regenerative mechanisms via induction of enhanced proliferative capacity in side population cells. 6 Thus, genetic manipulations may enhance the proliferation of differentiating cardiomyocytes for cardiac repair. Trans differentiation of MSC is controlled by factors in the microenvironment or supplied in the culture media of ex vivo cultivated cells. Mesenchymal stem cell do not differentiate spontaneously but do so in the presence of growth factors and cytokines. 20, 21 CXCR4 is a major regulator of stem/progenitor cell activities. 11 Our data demonstrates that MSC CX4 release paracrine factors, such as VEGF, cyclin A2, and TGFß2, that contribute to cell survival, proliferation, and angiogenesis ( Figure 3 ). MSC CX4 transplanted into the border zone migrate specifically toward the SDF-1 gradient in the ischemic myocardium in where they may release of certain cytokines to stimulate native cardiomyocyte proliferation. The cellular responses seem to work only in the microenvironment of the ischemic myocardium because they are not activated after transplantation into uninjured myocardium. 22 Mobilization and proliferation in a given tissue are dependent on the specific signals present in the local microenvironment of the damaged heart. Therefore, the ischemic microenvironment has critical patho-biological functions that are essential for seeding and proliferation of MSC in remodeling of damaged hearts.
Our data also demonstrate that transplantation of MSC CX4 exerts a marked inhibitory effect on pathological myocardial remodeling that may be important in mediating therapeutic benefit. Whether the effect on remodeling is due to mechanical improvement resulting from cell transplantation, angiogenesis, or paracrine mediators released by MSC CX4 still requires further investigation. A previous study has revealed a crosstalk between MSCs and cardiomyocytes, contributing to the inhibition of cardiac hypertrophy through synergistic VEGF release and via suppressing Ca 2+ /calcineurin/NFATc3 hypertrophic signals in cardiomyocytes. 23 Although our data did not indicate whether such an antihypertrophic response can be further tuned up in MSC CX4engrafted hearts, the MSC CX4 -induced paracrine responses actually enhanced the proliferation of neonatal and adult cardiomyocytes in vitro, [24] [25] [26] which supports the regenerative capacity of these MSC.
We have demonstrated that targeted genetic expression of 
